Bank Of New York Mellon Corp Ptc Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $32.8 Million - $53.7 Million	979,516 New	979,516 $37.4 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $107,805 - $138,717	-2,576 Reduced 0.25%	1,015,294 $51 Million
Q2 2022 Aug 15, 2022	SELL	$25.6 - $45.23 $1.24 Million - $2.19 Million	-48,525 Reduced 4.55%	1,017,870 $40.8 Million
Q1 2022 May 11, 2022	SELL	$33.33 - $44.6 $1.67 Million - $2.23 Million	-50,081 Reduced 4.49%	1,066,395 $39.8 Million
Q4 2021 Feb 11, 2022	SELL	$35.36 - $41.86 $3.81 Million - $4.51 Million	-107,751 Reduced 8.8%	1,116,476 $44.5 Million
Q3 2021 Nov 12, 2021	BUY	$37.01 - $44.74 $356,406 - $430,846	9,630 Added 0.79%	1,224,227 $45.6 Million
Q2 2021 Aug 11, 2021	BUY	$37.95 - $49.37 $15.5 Million - $20.2 Million	409,436 Added 50.85%	1,214,597 $51.3 Million
Q1 2021 May 13, 2021	BUY	$46.8 - $68.92 $1.39 Million - $2.05 Million	29,689 Added 3.83%	805,161 $38.1 Million
Q4 2020 Feb 09, 2021	BUY	$47.96 - $67.64 $1.51 Million - $2.12 Million	31,385 Added 4.22%	775,472 $47.3 Million
Q3 2020 Nov 12, 2020	SELL	$45.41 - $57.07 $13,214 - $16,607	-291 Reduced 0.04%	744,087 $34.8 Million
Q2 2020 Aug 12, 2020	BUY	$42.56 - $54.98 $16.9 Million - $21.9 Million	397,731 Added 114.74%	744,378 $37.8 Million
Q1 2020 May 06, 2020	BUY	$32.37 - $59.36 $891,048 - $1.63 Million	27,527 Added 8.63%	346,647 $15.5 Million
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $398,335 - $619,015	12,363 Added 4.03%	319,120 $15.3 Million
Q3 2019 Nov 07, 2019	SELL	$33.82 - $48.17 $85,868 - $122,303	-2,539 Reduced 0.82%	306,757 $10.4 Million
Q2 2019 Aug 12, 2019	BUY	$35.42 - $45.0 $268,908 - $341,640	7,592 Added 2.52%	309,296 $13.9 Million
Q1 2019 May 14, 2019	BUY	$28.09 - $39.49 $1.23 Million - $1.73 Million	43,700 Added 16.94%	301,704 $11.4 Million
Q4 2018 Feb 11, 2019	BUY	$29.83 - $46.51 $1.94 Million - $3.03 Million	65,061 Added 33.72%	258,004 $8.85 Million
Q3 2018 Nov 09, 2018	BUY	$33.9 - $47.77 $241,130 - $339,788	7,113 Added 3.83%	192,943 $0
Q2 2018 Aug 06, 2018	BUY	$25.7 - $47.88 $169,620 - $316,008	6,600 Added 3.68%	185,830 $6.27 Million
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $1,047 - $1,955	60 Added 0.03%	179,230 $4.85 Million
Q4 2017 Feb 09, 2018	BUY	$15.14 - $20.89 $2.71 Million - $3.74 Million	179,170	179,170 $2.99 Million

Others Institutions Holding PTCT

# of Institutions

223

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

Vanguard Group Inc Valley Forge, PA

9.13M
Shares

$358 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

7.89M
Shares

$310 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$305 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.39M
Shares

$290 Million
4.37% of portfolio
Armistice Capital, LLC New York, NY

7.23M
Shares

$284 Million
4.46% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account